CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of AKCEA-TTR-LRx in Participants With Transthyretin ‑Mediated Amyloid Cardiomyopathy (ATTR CM)

Condition:   Transthyretin‑Mediated Amyloid Cardiomyopathy (ATTR CM) Interventions:   Drug: AKCEA-TTR-LRx;   Drug: Placebo Sponsors:   Ionis Pharmaceuticals, Inc.;   Akcea Therapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials